Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Pharmaceutics
|
August 4, 2019
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
Janik Puttemans, Tony Lahoutte, Matthias D'Huyvetter, et al.
Molecular Pharmaceutics
|
March 6, 2018
Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 13, 2022
A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, et al.
EJNMMI Physics
|
February 23, 2022
Assessment of mouse-specific pharmacokinetics in kidneys based on <sup>131</sup>I activity measurements using micro-SPECT
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, et al.
Expert Opinion on Drug Delivery
|
July 19, 2014
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Matthias D'Huyvetter, Catarina Xavier, Vicky Caveliers, et al.
Nuclear Medicine and Biology
|
April 13, 2016
(18)F-nanobody for PET imaging of HER2 overexpressing tumors
Catarina Xavier, Anneleen Blykers, Ilse Vaneycken, et al.
Expert Opinion on Biological Therapy
|
May 5, 2016
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Yana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, et al.
New Biotechnology
|
March 26, 2018
Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
Ahmet Krasniqi, Magdalena Bialkowska, Catarina Xavier, et al.
Journal of Translational Medicine
|
November 5, 2024
CD38 as theranostic target in oncology
Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte, et al.
Current Opinion in Biotechnology
|
July 6, 2011
Immuno-imaging using nanobodies
Ilse Vaneycken, Matthias D'huyvetter, Sophie Hernot, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Pharmaceutics
|
August 4, 2019
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
Janik Puttemans, Tony Lahoutte, Matthias D'Huyvetter, et al.
Molecular Pharmaceutics
|
March 6, 2018
Evaluation of an Anti-HER2 Nanobody Labeled with <sup>225</sup>Ac for Targeted α-Particle Therapy of Cancer
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 13, 2022
A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, et al.
EJNMMI Physics
|
February 23, 2022
Assessment of mouse-specific pharmacokinetics in kidneys based on <sup>131</sup>I activity measurements using micro-SPECT
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, et al.
Expert Opinion on Drug Delivery
|
July 19, 2014
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Matthias D'Huyvetter, Catarina Xavier, Vicky Caveliers, et al.
Nuclear Medicine and Biology
|
April 13, 2016
(18)F-nanobody for PET imaging of HER2 overexpressing tumors
Catarina Xavier, Anneleen Blykers, Ilse Vaneycken, et al.
Expert Opinion on Biological Therapy
|
May 5, 2016
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Yana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, et al.
New Biotechnology
|
March 26, 2018
Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
Ahmet Krasniqi, Magdalena Bialkowska, Catarina Xavier, et al.
Journal of Translational Medicine
|
November 5, 2024
CD38 as theranostic target in oncology
Valentina Bocuzzi, Jessica Bridoux, Michelle Pirotte, et al.
Current Opinion in Biotechnology
|
July 6, 2011
Immuno-imaging using nanobodies
Ilse Vaneycken, Matthias D'huyvetter, Sophie Hernot, et al.
Page
of 5